A Study of Imvotamab in Severe Systemic Lupus Erythematosus

NCT06041568 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Company Decision.

Conditions

Interventions

Sponsor

IGM Biosciences, Inc.